((自动化翻译由路透提供，请见免责声明 ))
10月14日 - **Vanda Pharmaceuticals 股价盘前上涨21.2%至5.35美元
** 总部位于英国的Cycle Pharmaceuticals公司重申 (link)，以每股8美元的价格全现金收购旺达，收购价为4.88亿美元。
** Cycle表示，该收购方案与10月11日的万达股价相比溢价80%，而与2024年6月5日的股价相比溢价58%，2024年6月5日是Cycle首次公开收购要约的前一天。
** Cycle 于 6 月 (link) 6 日以每小时 8 美元的价格提出收购要约，但遭到万达拒绝。 (link)
** 该公司还在 9 月份发出了一份重申要约的建议书，但也于 10 月 7 日被万达拒绝。
** 截至上次收盘，股价年累计上涨 5.2
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.